Malaria is an infectious disease responsible for approximately one million deaths annually. Peptides such as angiotensin II (AII) and its analogs are known to have antimalarial effects against Plasmodium gallinaceum [1] and Plasmodium falciparum [2] . However, their mechanism of action is still not fully understood at the molecular level. In this work, we investigated this issue by comparing the antimalarial activity of angiotensin II with that of: i) its enantiomer formed by only D-amino acids; ii) its isomer with reversed sequence; and iii) its analogs restricted by lactam bridges -the so-called VC5 peptides.
Introduction
Malaria is an infectious disease responsible for approximately one million deaths annually. Peptides such as angiotensin II (AII) and its analogs are known to have antimalarial effects against Plasmodium gallinaceum [1] and Plasmodium falciparum [2] . However, their mechanism of action is still not fully understood at the molecular level. In this work, we investigated this issue by comparing the antimalarial activity of angiotensin II with that of: i) its enantiomer formed by only D-amino acids; ii) its isomer with reversed sequence; and iii) its analogs restricted by lactam bridges -the so-called VC5 peptides.
Results and Discussion
The peptides were synthesized manually with the t-Boc strategy on Merrifield resin (Table 1) . AII could inactivate 88% of the Plasmodium gallinaceum sporozoites, which is consistent with its known antimalarial properties. Similar anti-plasmodial effects were measured for ent-AII and other peptides ( Figure 1 ). In contrast to AII, ent-AII and retro-AII could not interact with the membrane AII-receptors ( Figure 2 ). This indicates that the anti-plasmodial effects of AII analogs depend on direct peptide-phospholipid interactions. This hypothesis was also supported by the anti-plasmodial activities recorded for the lactam bridge-restricted analogs VC5 and ent-VC5. These were comparable to that of AII. A significant change in the anti-plasmodial activity was observed only for retro-AII, which was ~6-fold less effective than AII. We used CD experiments to show that the β-turn was the most frequent 
Fig. 2. Effects of peptides on contractile responses during muscle tissue incubation compared to carbachol (CCh) activity. AT1 receptor recognition was analyzed via preincubation with Losartan (mean ± standard deviation, N = 2).
conformation adopted by peptides in aqueous and organic solvents. Moreover, the β-turn conformation was correlated with a larger antiplasmodial activity.
In the presence of SDS micelles, AII had a β-turn conformation while retro-AII presented a random coiled conformation (Figure 3) . Consistently, molecular dynamic simulations revealed that the AII chains were slightly more bent than retro-AII at the surface of a model phospholipid bilayer (Figure 4) . We did not observe spontaneous pore formation in either case. This may be an indication that this process involves larger time scales and possibly the organization of the peptide chains into larger assemblies. However, qualitative differences were identified between the behavior of AII and retro-AII by pulling both peptides across the phospholipid bilayer. At the hydrophobic membrane interior, the retro-AII chain was severely coiled and rigid. AII was much more flexible and could experience both straight and coiled conformations. Interactions between AII and phospholipid head groups were kept for a longer time even in the membrane interior. It is conceivable that stronger peptide-head group interactions might be more effective at stabilizing a pore in longer time scales. This contributes to the larger anti-plasmodial activity of AII versus retro-AII. We hope that our results can be used for the systematic design of novel compounds with antimalarial activity. 
